A Study to Compare Pharmacokinetics and Pharmacodynamics of Insulin Aspart to NovoRapid® Penfill® in Healthy Subjects
NCT04184466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2019-12-03
Summary
Pharmacokinetics and pharmacodynamics study of 2 formulations of insulin aspart (Insulin Aspart GEROPHARM vers. NovoRapid® Penfill® Novo Nordisk)
Conditions
- Clamp Study
Interventions
- DRUG
-
Insulin Aspart
insulin aspart in doses 0.3 IU/kg
- DRUG
-
NovoRapid® Penfill®
insulin aspart in doses 0.3 IU/kg
Sponsors & Collaborators
-
Geropharm
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- SINGLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-10-18
- Primary Completion
- 2018-12-19
- Completion
- 2018-12-19
Countries
- Russia
Study Locations
More Related Trials
-
A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes Mellitus
NCT03202875 ·Status: COMPLETED ·Phase: PHASE1
-
AT278 and NovoRapid® in Glucose Clamp Study
NCT04660305 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes
NCT00184613 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Aspart Produced by Current Process and the NN2000 Process
NCT01486914 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject
NCT05737576 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses
NCT00513643 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of the Pharmacokinetics of Rinsulin® Mix 30/70, Suspension for Subcutaneous Administration, 100 IU / ml (OJSC GEROPHARM-Bio, Russia) and Humulin® M3, Suspension for Subcutaneous Administration, 100 IU / ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
NCT04498884 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70.
NCT00283218 ·Status: COMPLETED ·Phase: NA
-
A Study to Compare Pharmacokinetics and Pharmacodynamics of RinGlar® to Lantus® in Type 1 Diabetes Mellitus Patients
NCT04101383 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Pharmacodynamics and Pharmacokinetics of Insulin Aspart and Human Insulin in Elderly People With Type 2 Diabetes
NCT00676819 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes
NCT01469143 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes
NCT01536028 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes
NCT00604656 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Investigating the Pharmacokinetic Properties of NN1218 in Subjects With Diabetes Mellitus, Type 1
NCT01296438 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Subjects With Type 1 Diabetes
NCT01924637 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of Two Insulatard® Formulations in Healthy Subjects
NCT01486901 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers
NCT05539872 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparative Glucose Clamp Study of Wockhardt's Human Isophane Insulin With Novolin N,in Healthy Subjects
NCT00772265 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Wockhardt's Glucose Clamp Study-Human Isophane Susp 30IU/ml/70IU/ml With Novolin70/30, in Healthy Subjects
NCT01358435 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Two Insulin Aspart Formulations in Healthy Volunteers
NCT01698697 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method
NCT04501250 ·Status: COMPLETED ·Phase: NA
-
Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes
NCT01526941 ·Status: COMPLETED ·Phase: PHASE1
-
Insulin NovoRapid Versus Actrapid in Treatment of Type 1 Diabetic Patients During Daily Adjustment of Insulin Dose
NCT00145353 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes
NCT02131246 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Actrapid, in Healthy Subjects.
NCT00719108 ·Status: COMPLETED ·Phase: PHASE1